Quick View
| Metric | Current Period | Prior-Year Period | YoY |
|---|---|---|---|
| Revenue | ¥104.4B | ¥91.6B | +14.0% |
| Operating Income | ¥6.8B | ¥4.3B | +56.5% |
| Ordinary Income | ¥6.3B | ¥3.7B | +70.6% |
| Net Income | ¥4.3B | ¥2.9B | +50.7% |
| ROE | 14.4% | 10.2% | - |
Executive Summary
Cumulative results for FY2026 Q3 delivered higher revenue and profits: Revenue ¥104.4B (from ¥91.6B in the same period of the prior year, +¥12.8B, +14.0%), Operating Income ¥6.8B (from ¥4.3B, +¥2.5B, +56.5%), Ordinary Income ¥6.3B (from ¥3.7B, +¥2.6B, +70.6%), and Net Income ¥4.3B (from ¥2.9B, +¥1.4B, +50.7%). In addition to double-digit top-line growth, operating leverage lifted the operating margin to 6.5% (from 4.7% a year ago, +1.8pt), markedly improving profitability. However, an impairment loss of ¥0.9B and a gain on sale of shares of a subsidiary of ¥0.4B were recognized, indicating the profit mix includes non-recurring items.
Key Financial Indicators
[Profitability] ROE 14.4% (above the industry median of 9.7%), Operating Margin 6.5% (from 4.7% a year ago, +1.8pt), Net Margin 4.1% (from 3.1% a year ago, +1.0pt), Return on Assets 4.0%. DuPont decomposition of ROE: Net Margin 4.1%, Asset Turnover 0.971x, Financial Leverage 3.59x. Tax burden coefficient 0.691, interest burden coefficient 0.923. Interest Coverage 11.78x, indicating ample capacity to service interest.
[Cash Quality] Cash and Deposits ¥16.3B (down from ¥23.5B a year ago, -30.7%), Short-term Debt Coverage 1.78x (Cash and Deposits/Short-term Borrowings).
[Investment Efficiency] Asset Turnover 0.971x.
[Financial Soundness] Equity Ratio 27.8% (from 22.6% a year ago, +5.2pt), Current Ratio 125.8%, Debt-to-Equity Ratio 2.59x, Interest-bearing debt ¥52.9B, Debt/Capital ratio 63.9%.
Cash Flow Analysis
Cash and Deposits decreased by ¥7.2B from ¥23.5B in the prior-year period to ¥16.3B (-30.7%), indicating a contraction in liquidity. Meanwhile, Retained Earnings increased by ¥4.3B from ¥5.9B to ¥10.2B (+73.3%), reflecting that Net Income of ¥4.3B fed into internal reserves. In working capital efficiency, Accounts Receivable declined substantially from ¥16.97B to ¥11.71B (-¥5.3B, -31.0%), showing strong progress in collections. Accounts Payable increased from ¥6.4B to ¥7.2B (+¥0.8B, +12.1%), suggesting appropriate management of payment terms. Short-term Borrowings remained flat at ¥9.1B, and of the ¥43.8B in Long-term Borrowings, ¥12.5B is scheduled for repayment within one year, necessitating repayment or refinancing over the next 12 months under the cash management plan. Cash and Deposits are 1.78x Short-term Borrowings, and cash coverage of total current liabilities is 0.78x; while short-term liquidity is secured, the decline in cash likely reflects deployment toward working capital improvement, capital expenditures, and debt repayment.
Quality of Earnings
Against Ordinary Income of ¥6.3B, Operating Income was ¥6.8B, implying net non-operating expenses of approximately ¥0.5B due to interest burden and foreign exchange gains/losses. Detailed disclosure of non-operating income is limited, but interest expense of ¥0.6B was recorded; the interest burden on Interest-bearing debt of ¥52.9B is around 1.1%. In extraordinary gains and losses, an impairment loss of ¥0.9B and a gain on sale of shares of a subsidiary of ¥0.4B were recognized, meaning roughly ¥0.5B of the ¥4.3B in Net Income stems from non-recurring items. The impairment is presumed to be a one-off treatment of underperforming assets, and the gain on sale likely reflects business reorganization; excluding these, the recurring earnings power on an operating basis is estimated at roughly 90% of reported Net Income. As evidenced by the substantial reduction in Accounts Receivable (-31.0%), working capital has improved, and accounting earnings are aligned with cash inflows; however, the decline in Cash and Deposits indicates that cash outflows for investment or financing exceeded collections.
Risk Factors
- High leverage structure: With a Debt-to-Equity Ratio of 2.59x (well above a D/E benchmark of 2.0) and a Debt/Capital ratio of 63.9%, rising interest rate environments could increase interest burden and pressure profitability. Long-term borrowings scheduled for repayment within one year total ¥12.5B, equivalent to 77% of Cash and Deposits of ¥16.3B; repayment scheduling and refinancing risk require monitoring.
- Shrinking cash buffer: Cash and Deposits declined sharply by -30.7% YoY, reducing the short-term financial buffer. With sales growth and investment needs coexisting, if Operating Cash Flow generation proves insufficient, the need for additional borrowing or capital raising could increase.
- Reliance on temporary profit items: An impairment of ¥0.9B and a gain on sale of ¥0.4B were recorded, with about 10% of the ¥4.3B in Net Income attributable to non-recurring factors. The recurrence of future impairments or special gains is limited, making the sustainability of profit generation from core operations a key point for verification.
Industry Benchmark (Reference, Our Estimates)
[Positioning within the Industry] (Reference information, our estimates) Profitability: Operating Margin 6.5% (1.7pt below the industry median of 8.2%), Net Margin 4.1% (1.6pt below the industry median of 5.7%), ROE 14.4% (4.7pt above the industry median of 9.7%), Return on Assets 4.0% (0.7pt below the industry median of 4.7%). Profitability trails the industry median on operating and net margins, but ROE significantly exceeds the median due to financial leverage. Soundness: Equity Ratio 27.8% (21.2pt below the industry median of 49.0%), Current Ratio 125.8% (well below the industry median of 206%), and Net Debt/EBITDA is positive; compared with the industry median of -1.75x, reliance on debt is markedly higher. Financial soundness ranks in the lower tier of the industry, with substantial room to improve capital structure. Growth: Revenue growth rate 14.0% (+4.5pt above the industry median of 9.5%), placing the company among the faster growers in the industry. While top-line expansion is steady, the balance between growth and margins, and consistency with cash flow, will be key evaluation points. Industry: Healthcare (N=44 companies), Comparison period: 2025-Q3 reporting, Source: Our compilation
Key Takeaways from Results
Key takeaways are as follows. First, the 14.0% Revenue growth rate and 56.5% Operating Income growth rate highlight the effect of operating leverage, confirming cost structure efficiencies during a sales expansion phase. Selling, general and administrative expense growth lagged revenue growth versus the prior year, improving Operating Margin by 1.8pt and suggesting a better earnings structure. Second, the duality in financial structure: ROE of 14.4% is well above the industry median, indicating strong shareholder capital efficiency; however, this is underpinned by high leverage with a Debt-to-Equity Ratio of 2.59x, while the Equity Ratio of 27.8% is well below the industry median of 49.0%. High leverage amplifies shareholder returns in upcycles but increases downside risk in adverse environments. Third, the divergence between working capital management and cash trends: while the large collection of receivables (-31.0%) indicates improved working capital efficiency, Cash and Deposits declined -30.7% over the same period. This divergence suggests collected funds were likely allocated to capital expenditures and debt repayment, necessitating verification of Free Cash Flow generation capacity. Progress against the full-year plan stands at 72.5% for revenue and 90.1% for operating income; revenue is tracking ahead of plan, but profit is broadly in line, implying limited room for incremental profit build in Q4.
This report is an automatically generated earnings analysis created by AI based on XBRL financial summary data. It does not constitute a recommendation to invest in any specific security. The industry benchmarks are reference information compiled by us from publicly available financial statements. Investment decisions are your own responsibility; consult a professional as needed before making any decisions.
AI Financial Analysis
Executive Summary
AIAI Group delivered a strong FY2026 Q3 cumulative earnings performance, with profit growth materially outpacing revenue growth and full-year operating-profit guidance already substantially covered. Revenue increased 14.0% year on year to ¥10.44bn. Operating income rose 56.5% to ¥676m. Ordinary income increased 70.6% to ¥631m. Net income attributable to owners grew 50.7% to ¥431m. The operating margin expanded by 150bp year on year to 6.5% from approximately 4.7%. The gross margin improved by 170bp to 17.2% from approximately 15.5%, indicating improved direct-cost absorption as revenue scaled. SG&A increased 13.2% to ¥1.11bn, slightly below the 14.0% revenue growth rate, supporting positive operating leverage. Net margin rose by 100bp to 4.1% from 3.1%. Ordinary income growth exceeded operating-income growth because non-operating expenses declined, although interest expense still represented ¥57m. The tax burden was moderately heavier than the normal benchmark, with an effective tax rate of 30.9% and a tax-burden factor of 0.691. Annualized ROE was high at 19.2%, supported by a 4.1% net margin, 1.295x asset turnover, and elevated 3.59x financial leverage. The balance sheet became smaller year on year as total assets declined 13.8% to ¥10.75bn and total liabilities declined 19.7% to ¥7.76bn, while equity increased 6.2% to ¥2.99bn. Receivables fell 31.0% and cash declined 30.7%, consistent with a substantial contraction in working capital and balance-sheet funding. Q3 cumulative revenue represents 72.5% of the ¥14.40bn full-year plan, marginally below the standard 75% seasonal run rate, whereas operating income represents 90.1% of the ¥750m target and net income represents 86.2% of the ¥500m target. The earnings trajectory supports the current profit plan, but the combination of thin gross margins, leverage, and a capital-intensive facility base means that sustained cost control and stable public-service reimbursement remain central to the outlook.
Profitability Analysis
The annualized DuPont ROE of 19.2% decomposes into a 4.1% net profit margin, 1.295x asset turnover, and 3.59x financial leverage. The principal driver of the strong ROE is leverage rather than an exceptionally high underlying margin, making the return profile more sensitive to financing costs and operating volatility. Revenue growth of 14.0% was converted into 56.5% operating-income growth, reflecting meaningful operating leverage. Gross profit increased 26.4% to ¥1.79bn, faster than revenue, and the gross margin rose 170bp to 17.2%. SG&A grew 13.2%, below sales growth, producing a further margin benefit and a 150bp improvement in operating margin to 6.5%. This is a favorable cost-control outcome, although the 17.2% gross margin remains below the 20% quality-alert threshold and leaves limited room to absorb labor-cost or reimbursement pressure. The interest-burden factor of 0.923 indicates that interest costs reduced EBIT by 7.7% before tax; this is manageable at the current 11.78x interest-coverage ratio but remains material for a leveraged operator. The tax-burden factor of 0.691 is slightly below the 0.70 normal benchmark, consistent with the 30.9% effective tax rate. Net income benefited from the absence of the prior-year's large impairment charge and other extraordinary items: extraordinary loss was only ¥7m in FY2026 Q3 versus ¥97m in the prior-year period. Accordingly, the improvement in net income is partly aided by a cleaner non-recurring item profile, but the larger contribution is the improvement in operating profit.
Growth Assessment
Growth was led by a 14.0% increase in revenue to ¥10.44bn and substantially stronger gross-profit conversion. The company has completed 72.5% of its full-year revenue plan at Q3, 2.5 percentage points below the standard 75% progress rate. This modest revenue shortfall versus a linear seasonal profile is offset by considerably stronger profit progress: operating income has reached 90.1% of the full-year target, ordinary income has reached 105.2% of plan, and net income has reached 86.2% of plan. The earnings outperformance implies that management's full-year operating-income forecast of ¥750m has a meaningful cushion if Q4 service demand and costs remain stable. However, ordinary income of ¥631m already exceeds the ¥600m full-year forecast, while the forecast assumes a 31.2% year-on-year decline in ordinary income; this suggests either conservatism in the forecast or expected Q4 non-operating costs. The underlying growth model depends on maintaining occupancy and enrollment across childcare and related care facilities, while extracting fixed-cost leverage from the existing network. Japan's demographic aging supports care-service demand, while demand for childcare services remains sensitive to local population, municipal capacity planning, and enrollment trends. In a regulated service model, reimbursement revisions and personnel costs can have a disproportionate impact because gross margin remains only 17.2%. One subsidiary was newly consolidated during the period, which may provide incremental scale but also raises execution requirements around operational integration.
Financial Health
Liquidity is adequate but not ample. The current ratio and quick ratio were both 125.8%, above 1.0x and indicating that current assets of ¥3.20bn exceed current liabilities of ¥2.54bn. Working capital was positive at ¥655m. Cash and deposits were ¥1.63bn, representing 15.1% of total assets and covering 64.0% of current liabilities. Accounts receivable declined by ¥526m, or 31.0%, to ¥1.17bn, reducing the funding tied up in operating receivables. Solvency remains the central balance-sheet risk: the reported debt-to-equity ratio was 2.59x, above the 2.0x warning threshold and consistent with aggressive debt financing. Debt-to-capital was 59.4%, close to the 60% concern threshold. Long-term loans were ¥4.38bn, equivalent to 40.8% of total assets, while the current portion of long-term loans was ¥1.25bn; refinancing capacity and interest-rate exposure therefore remain relevant. Interest coverage of 11.78x provides a meaningful current earnings buffer, but this buffer could narrow if margins weaken or borrowing costs rise. Asset retirement obligations were ¥462m, equal to 6.0% of liabilities and above the 5% quality-alert threshold. This obligation reflects the future restoration burden associated with leased or operated facilities, and it increases the fixed-commitment profile of a network-based care-services operator. Goodwill was limited at ¥40m, or 1.3% of equity, so balance-sheet value is not materially dependent on acquisition-related intangible assets.
Notable B/S Changes
Treasury stock: increased to ¥292m from a negligible balance - substantial share-repurchase-related capital use, equivalent to 9.7% of total equity and relevant to liquidity and deleveraging priorities. Retained earnings: +¥431m (+73.3%) to ¥1.02bn - reflects Q3 cumulative net income retention and strengthens the equity base. Accounts receivable: -¥526m (-31.0%) to ¥1.17bn - favorable working-capital release and lower collection exposure. Cash and deposits: -¥721m (-30.7%) to ¥1.63bn - liquidity remains adequate, but the reduction should be monitored against debt maturities and facility funding needs. Goodwill: -¥33m (-45.0%) to ¥40m - limited residual M&A balance and low impairment risk relative to equity. Intangible assets: -¥42m (-49.8%) to ¥42m - confirms immaterial intangible-asset dependence.
Cash Flow Quality
The reduction in trade receivables by ¥526m is supportive of cash conversion and reduces the amount of earnings tied up in billing and collection cycles. Cash and deposits declined by ¥721m to ¥1.63bn despite the improvement in profitability, indicating that funding uses, debt repayment, capital expenditure, treasury-share activity, or other balance-sheet movements remained significant during the period. The company has a capital-intensive operating structure, with property, plant and equipment of ¥5.56bn, including buildings of ¥4.84bn, equivalent to 51.7% and 45.0% of total assets, respectively. This fixed-asset intensity implies continuing maintenance, refurbishment, and facility-expansion funding requirements. Construction in progress decreased by ¥167m to ¥124m, which may indicate completion or moderation of development spending. Asset retirement obligations of ¥462m should be considered alongside facility-related investment requirements when assessing longer-term free-cash-flow capacity. The lower receivable balance is constructive, but maintaining collection discipline remains important because current liquidity is only moderately above current obligations.
Dividend Sustainability
The company reported a Q2 dividend per share of ¥0 and its full-year forecast also assumes ¥0 DPS. Accordingly, there is no current cash-dividend commitment requiring coverage by earnings or free cash flow. Retained earnings increased 73.3% year on year to ¥1.02bn, supported by ¥431m of Q3 cumulative net income. The absence of dividends allows internally generated earnings to support debt reduction, facility investment, and liquidity. Treasury stock increased to negative ¥292m on the balance sheet, equivalent to 208,626 shares held, indicating that capital allocation has included share repurchase activity rather than ordinary dividends. Because no cash dividend is forecast, dividend sustainability is not currently a constraint; the more relevant capital-allocation question is whether future surplus cash is prioritized toward deleveraging and facility investment versus additional buybacks.
Risk Assessment
Business risks include Childcare and care-service reimbursement risk: public reimbursement and municipal policy changes can pressure revenue and margins in a regulated service model., Labor-cost and staffing risk: nurse, childcare-worker, and care-worker shortages can raise wages, recruitment costs, and agency-staff reliance; this is particularly material given the 17.2% gross margin., Enrollment, occupancy, and regional demographic risk: lower birth rates, local population decline, or competition for users can reduce utilization and impair fixed-cost absorption across facilities., Facility operations and compliance risk: service quality, safeguarding, infection-control, licensing, and regulatory compliance failures could create reputational damage and operating disruption., Integration risk: the newly consolidated subsidiary requires operational and financial integration without diluting the improving margin profile..
Financial risks include High leverage: reported D/E of 2.59x exceeds the 2.0x warning threshold, increasing sensitivity of equity returns and covenant headroom to earnings volatility., Refinancing and interest-rate risk: ¥4.38bn of long-term loans and ¥1.25bn of current maturities create ongoing funding requirements; rising rates would increase the ¥57m interest burden., Fixed-asset and restoration-commitment risk: PPE totals ¥5.56bn and asset retirement obligations total ¥462m, limiting financial flexibility if facility economics weaken., Liquidity risk: current and quick ratios of 1.26x are adequate but provide a narrower buffer than a 1.5x healthy benchmark..
Key concerns include The high-ARO-ratio alert is material: asset retirement obligations equal 6.0% of liabilities, above the 5% alert level, and represent unavoidable future cash obligations tied to facilities., The low-gross-margin alert is material: a 17.2% gross margin is below the 20% threshold, so modest adverse changes in staffing costs, utilization, or reimbursement can materially affect operating profit., Profit guidance is heavily covered at Q3, but revenue progress is slightly below the standard seasonal pace; Q4 revenue delivery should be monitored alongside margin retention., The large treasury-stock balance of ¥292m should be assessed against the need to preserve liquidity and reduce leverage..
Investment Implications
Key takeaways include Revenue grew 14.0%, while operating income grew 56.5%, demonstrating strong operating leverage and a 150bp operating-margin expansion to 6.5%., Q3 cumulative operating income reached 90.1% of full-year guidance and ordinary income exceeded the full-year forecast, establishing a favorable earnings-positioning base., Annualized ROE of 19.2% is attractive, but its durability depends materially on the 3.59x financial-leverage component., Balance-sheet risk remains elevated because reported D/E is 2.59x and debt-to-capital is 59.4%, despite solid 11.78x interest coverage., Low goodwill exposure limits M&A-related impairment risk; goodwill is only 1.3% of equity..
Metrics to watch include Q4 revenue realization versus the ¥14.40bn full-year forecast, Operating margin and gross margin, particularly labor-cost and facility-cost absorption, Enrollment and occupancy trends by facility and geography, Interest expense, loan maturities, D/E ratio, and debt-to-capital ratio, Cash balance, receivable collection, facility capital expenditure, and asset-retirement-obligation funding, Capital allocation between debt reduction, facility investment, and treasury-share activity.
Regarding relative positioning, AIAI Group's current earnings momentum and annualized 19.2% ROE compare favorably with broad profitability benchmarks, but the return profile is more leveraged and margin-sensitive than that of a conservatively financed service operator. Its negligible goodwill exposure is a balance-sheet positive, while the combination of regulated revenue, labor intensity, substantial facilities, and above-threshold leverage warrants close attention to cash preservation and recurring margin resilience.